Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Recombinant APP (Solanezumab Biosimilar) anticorps

Cet anticorps anti-APP (Solanezumab Biosimilar) Chimeric Humanized (ABIN7597997) détecte spécifiquement APP (Solanezumab Biosimilar). L’anticorps est réactif avec des échantillons de Humain.
N° du produit ABIN7597997
565,05 €
Frais d'envoi 40,00 €, glace carbonique 20,00 € et TVA exclus
Destination: France
Envoi sous 10 à 13 jours ouvrables

Aperçu rapide pour Recombinant APP (Solanezumab Biosimilar) anticorps (ABIN7597997)

Antigène

APP (Solanezumab Biosimilar)

Type d'anticorp

Recombinant Antibody

Reactivité

Humain

Hôte

Humanized

Clonalité

Chimeric

Classe de qualité

Research Grade
  • Expression System

    Mammalian cells

    Fonction

    Research Grade Solanezumab Biosimilar Antibody

    Specificité

    AICD-57, A4, Beta-CTF, Protease nexin-II, Gamma-CTF(50), ABPP, S-APP-beta, APP, Abeta40, Abeta42, AID(59), Amyloid intracellular domain 59, AID(57), S-APP-alpha, Gamma-CTF(59), Beta-secretase C-terminal fragment, Amyloid-beta precursor protein, Amyloid precursor protein, Beta-APP42, PreA4, Alzheimer disease amyloid protein, APPI, PN-II, AICD-59, Alpha-secretase C-terminal fragment, Amyloid-beta A4 protein, Amyloid intracellular domain 57, CVAP, Amyloid intracellular domain 50, Beta-APP40, AD1, Cerebral vascular amyloid peptide, AID(50), Alpha-CTF, Gamma-CTF(57), AICD-50

    Purification

    Protein A or G purified from cell culture supernatant.

    Pureté

    >95 % by SDS-PAGE.

    Isotype

    IgG1 kappa
  • Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    1.8 mg/mL

    Buffer

    0.01M PBS, pH 7.4.

    Stock

    4 °C,-20 °C,-80 °C

    Stockage commentaire

    Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

    Date de péremption

    12 months
  • Antigène

    APP (Solanezumab Biosimilar)

    Autre désignation

    Solanezumab Biosimilar

    Classe de substances

    Biosimilar

    Sujet

    AICD-57, A4, Beta-CTF, Protease nexin-II, Gamma-CTF(50), ABPP, S-APP-beta, APP, Abeta40, Abeta42, AID(59), Amyloid intracellular domain 59, AID(57), S-APP-alpha, Gamma-CTF(59), Beta-secretase C-terminal fragment, Amyloid-beta precursor protein, Amyloid precursor protein, Beta-APP42, PreA4, Alzheimer disease amyloid protein, APPI, PN-II, AICD-59, Alpha-secretase C-terminal fragment, Amyloid-beta A4 protein, Amyloid intracellular domain 57, CVAP, Amyloid intracellular domain 50, Beta-APP40, AD1, Cerebral vascular amyloid peptide, AID(50), Alpha-CTF, Gamma-CTF(57), AICD-50

    UniProt

    P05067

    Numéro CAS

    955085-14-0
Vous êtes ici:
Chat with us!